We are live on ! Find out more
FA

Forefront Analytics Portfolio holdings

AUM $110M
1-Year Est. Return 18.54%
This Fund
S&P 500
This Quarter Est. Return
-3.33%
1 Year Est. Return
+18.54%
3 Year Est. Return
+33.55%
5 Year Est. Return
+24.76%
10 Year Est. Return
–
AUM
$269M
AUM Growth
-$29.5M
Cap. Flow
-$16.1M
Cap. Flow %
-5.99%
Top 10 Hldgs %
59.39%
Holding
73
New
9
Increased
39
Reduced
13
Closed
3

Top Buys

Rank Stock Value
1
HDV
iShares Core High Dividend ETF
HDV
+$813K
2
MTUM icon
iShares MSCI USA Momentum Factor ETF
MTUM
+$622K
3
EMLP icon
First Trust North American Energy Infrastructure Fund
EMLP
+$493K
4
BNDX icon
Vanguard Total International Bond ETF
BNDX
+$294K
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$260K

Top Sells

Rank Stock Value
1
CGW icon
Invesco S&P Global Water Index ETF
CGW
+$16.2M
2
LTPZ icon
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
+$3.17M
3
WIP icon
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
+$437K
4
JNJ icon
Johnson & Johnson
JNJ
+$328K
5
VT icon
Vanguard Total World Stock ETF
VT
+$259K

Sector Composition

Rank Sector Weight
1 Healthcare 1.08%
2 Financials 0.82%
3 Materials 0.29%
4 Technology 0.2%
5 Industrials 0.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HSIC icon
51
Henry Schein
HSIC
$10B
$228K 0.08%
+2,625
New +$214K
GILD icon
52
Gilead Sciences
GILD
$167B
$221K 0.08%
3,737
+175
+5% +$11.2K
DHR icon
53
Danaher
DHR
$144B
$216K 0.08%
+831
New +$208K
ESGD icon
54
iShares ESG Aware MSCI EAFE ETF
ESGD
$11.7B
$208K 0.08%
2,833
+4
+0.1% +$301
VRNA
55
DELISTED
Verona Pharma
VRNA
$179K 0.07%
35,656
+1,550
+5% +$9.02K
PRVB
56
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$166K 0.06%
22,602
+900
+4% +$5.38K
CDAK
57
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$122K 0.05%
+19,310
New +$121K
PSTX
58
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$121K 0.04%
26,770
+16,150
+152% +$72.8K
AGI icon
59
Alamos Gold
AGI
$11.9B
$120K 0.04%
14,250
– –
JSPR icon
60
Jasper Therapeutics
JSPR
$24.8M
$118K 0.04%
+3,255
New +$147K
GERN icon
61
Geron
GERN
$924M
$117K 0.04%
86,636
+2,100
+2% +$2.34K
DYAI icon
62
Dyadic International
DYAI
$45.9M
$102K 0.04%
33,671
+1,100
+3% +$4.12K
KGC icon
63
Kinross Gold
KGC
$27B
$94K 0.03%
16,000
– –
EIGR
64
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$87K 0.03%
361
+16
+5% +$2.53K
ORTX
65
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$72K 0.03%
9,974
+4,717
+90% +$46.2K
ANNX icon
66
Annexon
ANNX
$950M
$63K 0.02%
+22,285
New +$137K
SURF
67
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$62K 0.02%
+19,713
New +$69.1K
CTMX icon
68
CytomX Therapeutics
CTMX
$788M
$40K 0.01%
14,644
+900
+7% +$3.46K
ADAM
69
Adamas Trust
ADAM
$807M
$37K 0.01%
2,500
– –
PEI
70
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$6K ﹤0.01%
667
– –
JD icon
71
JD.com
JD
$40B
– –
-3,478
Closed -$244K
JNJ icon
72
Johnson & Johnson
JNJ
$609B
– –
-1,919
Closed -$328K
VT icon
73
Vanguard Total World Stock ETF
VT
$76.6B
– –
-2,408
Closed -$259K
1 2
3

Similar funds

NC
nVerses Capital Wellington, Florida $110M AUM
PXPO
Peak XV Partners Operations Trianon, Mauritius $110M AUM 43.09% 1-Year Est. Return
OWA
OakTrust Wealth Advisors Wilton, Connecticut $110M AUM
MCM
Masterton Capital Management New York $110M AUM 3.55% 1-Year Est. Return
AC
AWH Capital Dallas, Texas $110M AUM 44.24% 1-Year Est. Return
NA
NWM Advisors San Luis Obispo, California $110M AUM
NMC
New Mountain Capital New York $110M AUM 51.63% 1-Year Est. Return
BCM
Bond Capital Management San Francisco, California $110M AUM 16.91% 1-Year Est. Return

Forefront Analytics's Q1 2022 Portfolio in Review

As of Q1 2022, Forefront Analytics held 73 positions worth $269M, down 9.9% from $299M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Forefront Analytics withdrew a net $16.1M in Q1 2022, closing 3 positions and reducing 13 holdings. Its most notable exit was Johnson & Johnson, an estimated $328K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 1.1% of assets, up from 0.77% a quarter earlier, followed by Financials and Materials.

Against the trend, Forefront Analytics opened a new position in Vale worth $275K.

  • Forefront Analytics's largest Q1 2022 buy was Vale: 13,744 shares worth $275K.
  • Forefront Analytics added most to iShares Core High Dividend ETF in Q1 2022, an estimated $813K increase.
  • Forefront Analytics's biggest Q1 2022 reduction was Invesco S&P Global Water Index ETF, cutting an estimated $16.2M.
  • Forefront Analytics fully exited Johnson & Johnson in Q1 2022, selling an estimated $328K.
  • Forefront Analytics's ten largest holdings make up 59% of its $269M portfolio in Q1 2022.
  • Forefront Analytics opened 9 new positions and closed 3 in Q1 2022.
  • Forefront Analytics's portfolio value fell 9.9% quarter-over-quarter to $269M.

Based on Forefront Analytics's 13F filing for Q1 2022, filed 9 May 2022.